These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 20031678

  • 1. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.
    Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N, Ntalianis A, Muller O, Barbato E, Beleslin B, Sagic D, De Bruyne B, Bartunek J, Wijns W.
    Circ Cardiovasc Interv; 2008 Dec; 1(3):193-200. PubMed ID: 20031678
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study.
    Rusinaru D, Vrolix M, Verheye S, Chowdhary S, Schoors D, Di Mario C, Desmet W, Donohoe DJ, Ormiston JA, Knape C, Bezerra H, Lansky A, Wijns W, DESSOLVE II Investigators.
    Catheter Cardiovasc Interv; 2015 Dec 01; 86(7):1141-50. PubMed ID: 25044635
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
    Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW, Park CG, Seo HS, Oh DJ.
    JACC Cardiovasc Interv; 2008 Feb 01; 1(1):65-71. PubMed ID: 19393147
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coronary vasomotion one year after drug-eluting stent implantation: comparison of everolimus-eluting and paclitaxel-eluting coronary stents.
    Hamilos M, Ribichini F, Ostojic MC, Ferrero V, Orlic D, Vassanelli C, Karanovic N, Sarno G, Cuisset T, Vardas PE, Wijns W.
    J Cardiovasc Transl Res; 2014 Jun 01; 7(4):406-12. PubMed ID: 24794876
    [Abstract] [Full Text] [Related]

  • 8. Long-term coronary endothelial function after zotarolimus-eluting stent implantation. A 9 month comparison between zotarolimus-eluting and sirolimus-eluting stents.
    Shin DI, Seung KB, Kim PJ, Chang K, Choi JK, Jeon DS, Kim MJ, Lee MY, Chung WS.
    Int Heart J; 2008 Nov 01; 49(6):639-52. PubMed ID: 19075480
    [Abstract] [Full Text] [Related]

  • 9. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
    Togni M, Räber L, Cocchia R, Wenaweser P, Cook S, Windecker S, Meier B, Hess OM.
    Int J Cardiol; 2007 Aug 21; 120(2):212-20. PubMed ID: 17234280
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction.
    Shin DI, Kim PJ, Seung KB, Kim DB, Kim MJ, Chang K, Lim SM, Jeon DS, Chung WS, Baek SH, Lee MY.
    Int Heart J; 2007 Sep 21; 48(5):553-67. PubMed ID: 17998765
    [Abstract] [Full Text] [Related]

  • 14. Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent.
    Pendyala LK, Matsumoto D, Shinke T, Iwasaki T, Sugimoto R, Hou D, Chen JP, Singh J, King SB, Chronos N, Li J.
    JACC Cardiovasc Interv; 2012 Apr 21; 5(4):436-44. PubMed ID: 22516402
    [Abstract] [Full Text] [Related]

  • 15. Preserved endothelial vasomotor function after everolimus-eluting stent implantation.
    Roura G, Homs S, Ferreiro JL, Gomez-Lara J, Romaguera R, Teruel L, Sánchez-Elvira G, Ariza-Solé A, Gómez-Hospital JA, Cequier Á.
    EuroIntervention; 2015 Oct 21; 11(6):643-9. PubMed ID: 25022229
    [Abstract] [Full Text] [Related]

  • 16. Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion.
    Fernandes RW, Dantas JM, Oliveira DC, Bezerra HG, Brito FS, Lima VC.
    Arq Bras Cardiol; 2012 Apr 21; 98(4):290-8. PubMed ID: 22406990
    [Abstract] [Full Text] [Related]

  • 17. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents.
    Li J, Jabara R, Pendyala L, Otsuka Y, Shinke T, Hou D, Robinson K, Chronos N.
    JACC Cardiovasc Interv; 2008 Jun 21; 1(3):279-85. PubMed ID: 19463313
    [Abstract] [Full Text] [Related]

  • 18. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B, Silber S, Park SJ, Garcia E, Schuler G, Suryapranata H, Koolen J, Hauptmann KE, Wijns W, Morice MC, Carrie D, van Es GA, Nagai H, Detiege D, Paunovic D, Serruys PW, NOBORI 1 Clinical Investigators.
    Circ Cardiovasc Interv; 2009 Jun 21; 2(3):188-95. PubMed ID: 20031715
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents.
    Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, Koiwaya H, Ohtsuka M, Nakayoshi T, Itaya N, Chibana H, Kakuma T, Imaizumi T.
    JACC Cardiovasc Interv; 2012 Sep 21; 5(9):966-73. PubMed ID: 22995884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.